antithrombin III-Fc (Ampsouce)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameantithrombin III-Fc (Ampsouce)
Drug Alias NameN/A
ClassificationBiologics
Mechanisms of ActionAntithrombin-III replacementsProtease inhibitorsCoagulation factor inhibitors
TargetsCoagulation factorProtease
Therapy Area/IndicationsGenetic Diseases, InbornVenous Thrombosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesAmpsouce Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAmpsouce Inc
Active IndicationsN/A
Inactive IndicationsGenetic Diseases, InbornVenous Thrombosis

Other Information

ATC CodeN/A
Related LinksN/A